POSTER: MM-906 First-in-Human Study of JNJ-79635322 (JNJ-5322), a Novel Next-Generation Trispecific Antibody, in Patients With Relapsed/Refractory Multiple Myeloma: Initial Phase 1 Results
Year: 2025
Type: article
Authors: Hans Lee, Rakesh Popat, Cyrille Touzeau, Aurore Perrot, Sébastien Anguille, Albert Oriol, Nicolas Kint, Jo Caers, Monique C. Minnema, Martin Kaiser, Alfred Garfall, Jeffrey Matous, Larysa Sanchez, Azra Borogovac, Lionel Karlin, Laura Rosinol, Wilfried Roeloffzen, Saad Usmani, Cindy Varga, Darren Pan, Tadao Ishida, Pansy Minnick, M. Damiette Smit, Nikki Daskalakis, Thomas Prior, Maria Krevvata, Ashley Nguyen, Brandi Hilder, Daniel Jonathan, Joseph Weidman, Sangmin Lee, Maria-Victoria Mateos, Paula Rodriguez-Otero, Gala Vega, Niels WCJ van de Donk
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4413774241
